130 related articles for article (PubMed ID: 34953706)
1. Radiation therapy of pancreatic cancers.
Huguet F; Rivin Del Campo E; Orthuon A; Mornex F; Bessières I; Guimas V; Vendrely V
Cancer Radiother; 2022; 26(1-2):259-265. PubMed ID: 34953706
[TBL] [Abstract][Full Text] [Related]
2. [Radiation therapy of pancreatic cancer].
Huguet F; Mornex F; Orthuon A
Cancer Radiother; 2016 Sep; 20 Suppl():S169-73. PubMed ID: 27523418
[TBL] [Abstract][Full Text] [Related]
3. Organs at risk radiation dose constraints.
Noël G; Antoni D
Cancer Radiother; 2022; 26(1-2):59-75. PubMed ID: 34953713
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy of cervical cancer.
Chargari C; Peignaux K; Escande A; Renard S; Lafond C; Petit A; Lam Cham Kee D; Durdux C; Haie-Méder C
Cancer Radiother; 2022; 26(1-2):298-308. PubMed ID: 34955418
[TBL] [Abstract][Full Text] [Related]
5. External irradiation treatment process.
Barillot I; Azria D; Lisbona A; Mahé MA
Cancer Radiother; 2022; 26(1-2):20-28. PubMed ID: 34953717
[TBL] [Abstract][Full Text] [Related]
6. AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer.
Oar A; Lee M; Le H; Wilson K; Aiken C; Chantrill L; Simes J; Nguyen N; Barbour A; Samra J; Sjoquist KM; Moore A; Espinoza D; Gebski V; Yip S; Chu J; Kneebone A; Goldstein D
BMC Cancer; 2021 Aug; 21(1):936. PubMed ID: 34412605
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy for cancers of the oesophagus, cardia and stomach.
Créhange G; Modesto A; Vendrely V; Quéro L; Mirabel X; Rétif P; Huguet F
Cancer Radiother; 2022; 26(1-2):250-258. PubMed ID: 34955417
[TBL] [Abstract][Full Text] [Related]
8. FOLFIRINOX-based neoadjuvant chemoradiotherapy for borderline and locally advanced pancreatic cancer: A pilot study from a tertiary centre.
Pouypoudat C; Buscail E; Cossin S; Cassinotto C; Terrebonne E; Blanc JF; Smith D; Marty M; Dupin C; Laurent C; Dabernat S; Chiche L; Vendrely V
Dig Liver Dis; 2019 Jul; 51(7):1043-1049. PubMed ID: 31000479
[TBL] [Abstract][Full Text] [Related]
9. Rectal cancer radiotherapy.
Vendrely V; Rivin Del Campo E; Modesto A; Jolnerowski M; Meillan N; Chiavassa S; Serre AA; Gérard JP; Créhanges G; Huguet F; Lemanski C; Peiffert D
Cancer Radiother; 2022; 26(1-2):272-278. PubMed ID: 34953708
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy for hypopharynx cancers.
Pointreau Y; Biau J; Delaby N; Thariat J; Lapeyre M
Cancer Radiother; 2022; 26(1-2):199-205. PubMed ID: 34953703
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy of anal canal cancer.
Peiffert D; Huguet F; Vendrely V; Moureau-Zabotto L; Rivin Del Campo E; Créhange G; Dietmann AS; Moignier A
Cancer Radiother; 2022; 26(1-2):279-285. PubMed ID: 34955416
[TBL] [Abstract][Full Text] [Related]
12. Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer.
Barnes CA; Aldakkak M; Christians KK; Clarke CN; Dua K; George B; Ritch PS; Kamgar M; Hall WA; Kulkarni N; Erickson BA; Evans DB; Tsai S
Surgery; 2020 Sep; 168(3):440-447. PubMed ID: 32641278
[TBL] [Abstract][Full Text] [Related]
13. Hepatic tumours and radiotherapy.
Rio E; Mornex F; Maingon P; Peiffert D; Parent L
Cancer Radiother; 2022; 26(1-2):266-271. PubMed ID: 34953707
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.
Katz MH; Shi Q; Ahmad SA; Herman JM; Marsh Rde W; Collisson E; Schwartz L; Frankel W; Martin R; Conway W; Truty M; Kindler H; Lowy AM; Bekaii-Saab T; Philip P; Talamonti M; Cardin D; LoConte N; Shen P; Hoffman JP; Venook AP
JAMA Surg; 2016 Aug; 151(8):e161137. PubMed ID: 27275632
[TBL] [Abstract][Full Text] [Related]
15. Role of radiotherapy in the management of bladder cancer: Recommendations of the French society for radiation oncology.
Fabiano E; Riou O; Pointreau Y; Périchon N; Durdux C
Cancer Radiother; 2022; 26(1-2):315-322. PubMed ID: 34955411
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy for nasopharyngeal cancer.
Blanchard P; Biau J; Huguet F; Racadot S; Berthold C; Wong-Hee-Kam S; Biston MC; Maingon P
Cancer Radiother; 2022; 26(1-2):168-173. PubMed ID: 34953699
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy for laryngeal cancers.
Biau J; Pointreau Y; Blanchard P; Khampan C; Giraud P; Lapeyre M; Maingon P
Cancer Radiother; 2022; 26(1-2):206-212. PubMed ID: 34953705
[TBL] [Abstract][Full Text] [Related]
18. Lung metastases radiation therapy.
Lévy A; Darréon J; Mornex F; Giraud P; Thureau S
Cancer Radiother; 2022; 26(1-2):244-249. PubMed ID: 34953714
[TBL] [Abstract][Full Text] [Related]
19. Role of radiotherapy in the management of vulvar cancer: Recommendations of the French society for radiation oncology.
Chargari C; Petit A; Escande A; Peignaux K; Lafond C; Peiffert D; Hannoun-Lévi JM; Durdux C; Haie-Méder C
Cancer Radiother; 2022; 26(1-2):286-291. PubMed ID: 34953710
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic ductal adenocarcinoma: tumour regression grading following neoadjuvant FOLFIRINOX and radiation.
Neyaz A; Tabb ES; Shih A; Zhao Q; Shroff S; Taylor MS; Rickelt S; Wo JY; Fernandez-Del Castillo C; Qadan M; Hong TS; Lillemoe KD; Ting DT; Ferrone CR; Deshpande V
Histopathology; 2020 Jul; 77(1):35-45. PubMed ID: 32031712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
